Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
American Heart Journal|December 17, 2011
Eliminating untimely deaths of women from heart disease: highlights from the Minnesota Women's Heart SummitRuth Lindquist, Jackie L Boucher, Elizabeth Zane Grey, et al.
Population Health Management|February 9, 2012
The Heart of New Ulm Project: using community-based cardiometabolic risk factor screenings in a rural population health improvement initiativeJeffrey J VanWormer, Pamela Jo Johnson, Raquel F Pereira, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2013
Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomasAngela J Sievert, Shih-Shan Lang, Katie L Boucher, et al.
Preventive Medicine|April 11, 2018
Assessing the impact of the heart of New Ulm Project on cardiovascular disease risk factors: A population-based program to reduce cardiovascular diseaseAbbey C Sidebottom, Arthur Sillah, David M Vock, et al.
Nature Immunology|September 1, 2014
Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated helminth expulsionFei Chen, Wenhui Wu, Ariel Millman, et al.
American Heart Journal|May 16, 2016
Changes in cardiovascular risk factors after 5 years of implementation of a population-based program to reduce cardiovascular disease: The Heart of New Ulm ProjectAbbey C Sidebottom, Arthur Sillah, Michael D Miedema, et al.
Ear and Hearing|April 1, 1996
Frequency-specific audiometry using steady-state responsesO G Lins, T W Picton, B L Boucher, et al.
Bioconjugate Chemistry|July 16, 2011
New covalent capture probes for imaging and therapy, based on a combination of binding affinity and disulfide bond formationTolulope A Aweda, Vahid Eskandari, David L Kukis, et al.
Chemical Research in Toxicology|December 19, 2003
Reduction of nilutamide by NO synthases: implications for the adverse effects of this nitroaromatic antiandrogen drugK Ask, S Dijols, C Giroud, et al.
Psychological Medicine|September 28, 2020
A randomized controlled trial of cognitive remediation and long-acting injectable risperidone after a first episode of schizophrenia: improving cognition and work/school functioningKeith H Nuechterlein, Joseph Ventura, Kenneth L Subotnik, et al.
Pageof 17